| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| EXELIXIS, INC. | EVP, Prod Dev & Med Aff &CMO | Common Stock | 307,654 | $7,032,970 | $22.86 | 03 Apr 2023 | Direct |
| Mural Oncology plc | Chief Medical Officer | Stock Option (right to buy) | 0 | $217,750 | $3.35 | 05 Dec 2025 | Direct |
| Mural Oncology plc | Chief Medical Officer | Ordinary Shares | 0 | $0 | $2.07 | 05 Dec 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| MURA | Mural Oncology plc | 05 Dec 2025 | 3 | $0 | 4 | Chief Medical Officer | 05 Dec 2025, 08:45 |
| MURA | Mural Oncology plc | 10 Nov 2025 | 1 | -$10,475 | 4 | Chief Medical Officer | 10 Nov 2025, 18:30 |
| MURA | Mural Oncology plc | 03 Mar 2025 | 2 | $0 | 4 | Chief Medical Officer | 05 Mar 2025, 16:47 |
| MURA | Mural Oncology plc | 24 Feb 2025 | 1 | -$51,294 | 4 | Chief Medical Officer | 25 Feb 2025, 16:03 |
| MURA | Mural Oncology plc | 07 Nov 2024 | 1 | -$16,880 | 4 | Chief Medical Officer | 08 Nov 2024, 16:02 |
| MURA | Mural Oncology plc | 14 Dec 2023 | 2 | $0 | 4 | Chief Medical Officer | 18 Dec 2023, 16:30 |
| MURA | Mural Oncology plc | 15 Nov 2023 | 0 | $0 | 3 | Chief Medical Officer | 15 Nov 2023, 16:01 |
| EXEL | EXELIXIS, INC. | 03 Apr 2023 | 1 | $0 | 4 | EVP, Prod Dev & Med Aff &CMO | 05 Apr 2023, 20:24 |
| EXEL | EXELIXIS, INC. | 15 Feb 2023 | 1 | -$312,766 | 4 | EVP, Prod Dev & Med Aff &CMO | 17 Feb 2023, 20:38 |
| EXEL | EXELIXIS, INC. | 04 Jan 2022 | 2 | -$146,017 | 4 | EVP, Prod Dev & Med Aff &CMO | 06 Jan 2022, 19:02 |
| EXEL | EXELIXIS, INC. | 04 Jan 2022 | 0 | $0 | 3 | EVP, Prod Dev & Med Aff &CMO | 06 Jan 2022, 18:58 |